LOXL2 and esophageal squamous cell carcinoma: Clinical data showed that positive LOXL2 expression was associated with tumor proliferation, so the effect of LOXL2 silencing and overexpression on ESCC cell proliferation was examined using the Cell Counting Kit-8 (CCK-8) assay.